(Q57382340)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7781267%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

title

Moclobemide, a substrate of CYP2C19 and an inhibitor of CYP2C19, CYP2D6, and CYP1A2: a panel study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7781267%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7781267%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

L F Gram

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7781267%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

T W Guentert

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7781267%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

S Grange

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7781267%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

K Vistisen

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7781267%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

language of work or name

English

0 references

publication date

1 June 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7781267%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

25 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7781267%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7781267%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7781267%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

page(s)

670-677

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7781267%20AND%20SRC:MED&resulttype=core&format=json

Moclobemide treatment causes a substantial rise in the sparteine metabolic ratio. Danish University Antidepressant Group

25 October 2019

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1016%2F0009-9236%2895%2990230-9

Mephenytoin and sparteine oxidation: genetic polymorphisms in Denmark

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1016%2F0009-9236%2895%2990230-9

Inhibitors of imipramine metabolism by human liver microsomes

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1016%2F0009-9236%2895%2990230-9

10.1016/0009-9236(95)90230-9

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7781267%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7781267%20AND%20SRC:MED&resulttype=core&format=json